Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
CoinShares Turns Crypto Volatility Into Profit, Eyes U.S. Expansion
CoinShares Turns Crypto Volatility Into Profit, Eyes U.S. Expansion

- CoinShares reported a 1.9% net profit increase to $32.4M in Q2 2025, driven by higher asset management fees and treasury gains. - AUM surged 26% to $3.46B as crypto prices rose 29-37% for Bitcoin/Ethereum, boosting ETP inflows to $170M. - The firm plans a U.S. listing to tap broader investors and favorable regulation, citing Circle/Bullish's successful listings as precedent. - Capital Markets unit showed resilience with $4.3M ETH staking income and diversified gains from lending/trading strategies.

ainvest·2025/08/29 11:33
Bitcoin News Today: Bitcoin's $10T Path: DeFi Turns Digital Gold into Financial Weapon
Bitcoin News Today: Bitcoin's $10T Path: DeFi Turns Digital Gold into Financial Weapon

- Cardano founder Charles Hoskinson predicts Bitcoin could hit $10T market cap in 5 years via DeFi-driven financial utility. - Achieving this would require $500,000/coin price with 20M BTC supply, surpassing gold and major corporations' valuations. - U.S. GENIUS Act establishes stablecoin regulations while banks fear deposit outflows from crypto competition. - Institutional adoption (e.g., U.S. government's 212k BTC) and DeFi innovations in yield generation support Bitcoin's financial integration.

ainvest·2025/08/29 11:33
Arctic Pablo Coin: A High-Yield, Deflationary Meme Coin with Explosive Presale ROI Potential
Arctic Pablo Coin: A High-Yield, Deflationary Meme Coin with Explosive Presale ROI Potential

- Arctic Pablo Coin (APC) introduces a deflationary model with weekly token burns and aggressive Stage 38 presale incentives, contrasting with Bonk and Pudgy Penguins. - Its 66% APY staking rewards and BONUS100 referral code amplify returns, offering $1,000 investments potential 11,263% ROI if token reaches $0.10. - Institutional audits by SCRL and Hacken validate APC's transparency, differentiating it from rug-pull-prone meme coins through systematic supply reduction and liquidity mechanisms. - With $3.65

ainvest·2025/08/29 11:30
Corporate Bitcoin Buying: Why Institutional Adoption Is Now Outpacing Miner Influence
Corporate Bitcoin Buying: Why Institutional Adoption Is Now Outpacing Miner Influence

- Institutional investors and corporate treasuries now dominate Bitcoin markets, outpacing miner influence through strategic accumulation and ETF inflows. - MicroStrategy holds $73.96 billion in BTC (629,376 coins), creating structural scarcity while institutional ETFs like BlackRock’s IBIT manage $132.5 billion in assets. - Regulatory clarity (CLARITY/GENIUS Acts) and U.S. Strategic Bitcoin Reserve plans reinforce Bitcoin’s legitimacy as a corporate reserve asset and hedge against fiat devaluation. - Inst

ainvest·2025/08/29 11:30
Assessing the High-Risk, High-Reward Potential of Donald Trump-Backed WLFI as the Altcoin Season Gains Momentum
Assessing the High-Risk, High-Reward Potential of Donald Trump-Backed WLFI as the Altcoin Season Gains Momentum

- Trump-backed WLFI token gains traction in 2025 altcoin season, blending institutional support with political branding and $1 price targets. - On-chain metrics show rising active addresses (705.9K monthly) but weak liquidity (€239.48K 30-day volume) and post-launch futures drops (-44%) signal market skepticism. - Centralization risks emerge via Trump family's 37.5% stake and Ethereum-based WLFI's zero circulating supply, challenging governance credibility. - Regulatory alignment with USD1 stablecoin offer

ainvest·2025/08/29 11:30
Tokenized US Treasuries: A Strategic Cornerstone in the RWA Revolution
Tokenized US Treasuries: A Strategic Cornerstone in the RWA Revolution

- Tokenized U.S. Treasuries surged to $7.45B in August 2025, growing 256% YoY driven by institutional demand for blockchain-based liquidity. - BlackRock’s BUIDL fund dominates 32% of the market, offering 24/7 liquidity and serving as collateral on crypto platforms like Deribit. - Top five tokenized Treasury products control 73.6% of the market, blending U.S. government-backed safety with digital finance efficiency. - Regulatory clarity and real-time settlement advantages position tokenized Treasuries as a

ainvest·2025/08/29 11:30
Flash
12:15
Bernstein: The Strength of Data Center REITs Is Underestimated by Indicators
According to Odaily, Bernstein analysts stated in a research report that the strength of data center real estate investment trusts (REITs) is often underestimated. This is because traditional valuation metrics often fail to reflect the long-term value of capital-intensive assets designed to generate cash flow over decades. Adjusted operating cash flow and development return rates, two sector-specific indicators, can more accurately assess this segment’s growth potential. While maintaining shareholder distributions, this sector is able to reinvest funds to expand data center computing power, which is a key advantage. Overall, Bernstein remains optimistic about the outlook for data center REITs. (Golden Ten Data)
12:13
SecondFi: Final Balance Snapshot Completed, Asset Redistribution Expected to Start in Approximately Two Weeks
BlockBeats News, June 26th, SecondFi Update on Incident Funds Recovery Progress: The final balance snapshot was taken on June 26th as an accurate record for the subsequent asset recovery. The engineering and security teams have completed balance verification and recovery mechanism evaluation. It is expected that asset returns will begin in approximately two weeks, with about one week for the implementation of the solution and another week for testing and review, with the specific timeline subject to adjustment based on progress. SecondFi has stated that it will resume operations after confirming the platform's security and completing all security reviews. Currently, users only need to submit an application via a support ticket and are not required to take any other actions.
12:12
Replimune Group Inc. announced that the U.S. Food and Drug Administration (FDA) has officially accepted its resubmitted Biologics License Application (BLA) for the investigational therapy RP1 for the treatment of advanced melanoma.
This acceptance marks a critical step for the company in advancing the marketing process of this oncolytic virus immunotherapy. The FDA has set the Prescription Drug User Fee Act (PDUFA) target review date as December 25, 2024. The submission of this BLA is primarily based on key CERPASS clinical trial data, which evaluated the efficacy and safety of combining RP1 with the anti-PD-1 therapy librolizumab compared to using librolizumab alone in patients with advanced melanoma.
News